Abstract
Background: MicroRNAs (miRNA) are known to play a key role in the etiology and treatment of epilepsy through controlling the expression of gene. However, miR-125a-5p in the epilepsy is little known. Epilepsy in rat models was induced by Pentylenetetrazol (PTZ) and miR- 125a-5p profiles in the hippocampus were investigated in our experiment. Also, the relationship between miR-125a-5p and calmodulin-dependent protein kinase IV (CAMK4) was identified and the related mechanism was also illustrated.
Methods: The miR-125a-5p mRNA expression levels were evaluated by quantitative real time polymerase chain reaction (qRT-PCR). Western Blot (WB) was used to analyze the CAMK4 protein expression levels. Seizure score, latency and duration were determined based on a Racine scale. The enzyme-linked immunosorbent assay (ELISA) was used to analyze the inflammatory factor expression. The relationship between miR-125a-5p and CAMK4 was detected through dual luciferase assay.
Results: Downregulation of miR-125a-5p was observed in the hippocampus of PTZ-induced epilepsy rats. The overexpression of miR-125a-5p attenuated seizure and decreased inflammatory factor level in the hippocampus of PTZ-induced rats. The miR-125a-5p alleviated epileptic seizure and inflammation in PTZ-induced rats by suppressing its target gene, CAMK4.
Conclusion: miR-125a-5p may represent a novel therapeutic treatment for PTZ-induced epilepsy by preventing the activation of CAMK4.
Keywords: Pentylenetetrazol, epilepsy, miR-125a-5p, CAMK4, dysfunction and inflammation, ELISA.
[http://dx.doi.org/10.1212/WNL.0000000000004806] [PMID: 29247076]
[http://dx.doi.org/10.1016/j.seizure.2018.03.023] [PMID: 29609146]
[http://dx.doi.org/10.1101/cshperspect.a028043] [PMID: 27371672]
[http://dx.doi.org/10.1038/jcbfm.2009.186] [PMID: 19724284]
[http://dx.doi.org/10.1016/j.expneurol.2012.06.029] [PMID: 22771761]
[http://dx.doi.org/10.1016/j.brainres.2011.12.001] [PMID: 22197703]
[http://dx.doi.org/10.1097/WCO.0000000000000079] [PMID: 24553459]
[http://dx.doi.org/10.1016/j.neuroscience.2013.02.027] [PMID: 23485811]
[http://dx.doi.org/10.1016/j.eplepsyres.2016.09.019] [PMID: 27694013]
[http://dx.doi.org/10.1016/j.brainres.2015.06.046] [PMID: 26168887]
[http://dx.doi.org/10.1016/j.brainres.2016.02.045] [PMID: 26947618]
[http://dx.doi.org/10.1021/acschemneuro.6b00222] [PMID: 27609046]
[http://dx.doi.org/10.1016/j.it.2008.08.005] [PMID: 18930438]
[http://dx.doi.org/10.1172/JCI73411] [PMID: 24667640]
[http://dx.doi.org/10.1002/art.30085] [PMID: 20954187]
[http://dx.doi.org/10.4049/jimmunol.1501603] [PMID: 26561550]
[http://dx.doi.org/10.1172/JCI38857] [PMID: 19741297]
[http://dx.doi.org/10.3892/mmr.2018.8441] [PMID: 29344671]
[PMID: 25558171]
[http://dx.doi.org/10.1016/j.eplepsyres.2006.05.011] [PMID: 16787740]
[http://dx.doi.org/10.1007/s00702-014-1291-2] [PMID: 25139483]
[http://dx.doi.org/10.3233/JIN-170035] [PMID: 29376880]
[PMID: 26722477]
[http://dx.doi.org/10.1002/syn.21952] [PMID: 27997735]
[http://dx.doi.org/10.1038/nrn2501] [PMID: 18854855]
[http://dx.doi.org/10.3390/brainsci7120157] [PMID: 29182556]
[http://dx.doi.org/10.3389/fncel.2015.00023] [PMID: 25767434]
[http://dx.doi.org/10.1016/S1474-4422(10)70310-0] [PMID: 21256455]
[http://dx.doi.org/10.1126/stke.3562006re12] [PMID: 17033045]
[http://dx.doi.org/10.1038/srep10201] [PMID: 25984652]
[http://dx.doi.org/10.1038/srep09522] [PMID: 25825351]
[http://dx.doi.org/10.1007/s12031-019-01386-w] [PMID: 31368064]
[http://dx.doi.org/10.1016/j.brainresbull.2019.07.021] [PMID: 31336125]
[http://dx.doi.org/10.1186/1471-2407-10-318] [PMID: 20569443]
[http://dx.doi.org/10.1371/journal.pone.0069118] [PMID: 23874885]